KUS121

· Kyoto Drug Discovery and Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KUS121, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO) [Phase 2]

See pricing